{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T15:57:50Z","timestamp":1791734270790,"version":"4.3.4"},"reference-count":44,"publisher":"SAGE Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CBM"],"published-print":{"date-parts":[[2020,3,3]]},"DOI":"10.3233\/cbm-190258","type":"journal-article","created":{"date-parts":[[2019,12,10]],"date-time":"2019-12-10T11:11:16Z","timestamp":1575976276000},"page":"313-323","source":"Crossref","is-referenced-by-count":9,"title":["Predictive value of unmethylated RASSF1A on disease progression in non-small cell lung cancer patients receiving pemetrexed-based chemotherapy"],"prefix":"10.1177","volume":"27","author":[{"given":"Qinfang","family":"Deng","sequence":"first","affiliation":[{"name":"Medical College of Soochow University, Soochow, China"},{"name":"Department of Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China"},{"name":"Medical College of Soochow University, Soochow, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Su","sequence":"additional","affiliation":[{"name":"Central Laboratory, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China"},{"name":"Medical College of Soochow University, Soochow, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianxiu","family":"Ji","sequence":"additional","affiliation":[{"name":"Department of Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiyu","family":"Fang","sequence":"additional","affiliation":[{"name":"Department of Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songwen","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caicun","family":"Zhou","sequence":"additional","affiliation":[{"name":"Medical College of Soochow University, Soochow, China"},{"name":"Department of Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/CBM-190258_ref1","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1056\/NEJMoa011954","article-title":"Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer","volume":"346","author":"Schiller","year":"2002","journal-title":"N Engl J Med"},{"key":"10.3233\/CBM-190258_ref2","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/annonc\/mdl377","article-title":"Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan","volume":"18","author":"Ohe","year":"2007","journal-title":"Ann Oncol"},{"key":"10.3233\/CBM-190258_ref3","doi-asserted-by":"crossref","first-page":"iv192","DOI":"10.1093\/annonc\/mdy275","article-title":"Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. ESMO Guidelines Committee","volume":"29","author":"Planchard","year":"2018","journal-title":"Ann Oncol"},{"key":"10.3233\/CBM-190258_ref4","doi-asserted-by":"crossref","first-page":"R95","DOI":"10.1093\/hmg\/ddl095","article-title":"The emerging science of epigenomics","volume":"1","author":"Callinan","year":"2006","journal-title":"Hum Mol Genet"},{"key":"10.3233\/CBM-190258_ref5","first-page":"1453","article-title":"Aberrant DNA methylation in non-small cell lung cancer-associated fibroblasts","volume":"36","author":"Vizoso","year":"2015","journal-title":"Carcinogenesis"},{"key":"10.3233\/CBM-190258_ref6","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.cell.2015.08.046","article-title":"Tracing dynamic changes of DNA methylation at single-cell resolution","volume":"163","author":"Stelzer","year":"2015","journal-title":"Cell"},{"key":"10.3233\/CBM-190258_ref7","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nrc1432","article-title":"Gene-promoter hypermethylation as a biomarker in lung cancer","volume":"4","author":"Belinsky","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.3233\/CBM-190258_ref8","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/nrg2005","article-title":"Cancer epigenomics: DNA methylomes and histone-modification maps","volume":"8","author":"Esteller","year":"2007","journal-title":"Nat Rev Genet"},{"key":"10.3233\/CBM-190258_ref9","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1586\/erm.13.37","article-title":"Epigenetic biomarkers in laboratory diagnostics: emerging approaches and opportunities","volume":"13","author":"Sandoval","year":"2013","journal-title":"Expert Rev Mol Diagn"},{"key":"10.3233\/CBM-190258_ref10","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.gde.2012.02.008","article-title":"Cancer epigenomics: beyond genomics","volume":"22","author":"Sandoval","year":"2012","journal-title":"Curr Opin Genet Dev"},{"key":"10.3233\/CBM-190258_ref11","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0168-9525(99)01971-X","article-title":"DNA hypermethylation in tumorigenesis: epigenetics joins genetics","volume":"16","author":"Baylin","year":"2000","journal-title":"Trends Genet"},{"key":"10.3233\/CBM-190258_ref12","first-page":"825","article-title":"Performance evaluation of the DNA methylation biomarker SHOX2 for the aid in diagnosis of lung cancer based on the analysis of bronchial aspirates","volume":"40","author":"Dietrich","year":"2012","journal-title":"Int J Oncol"},{"key":"10.3233\/CBM-190258_ref13","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.7150\/jca.21368","article-title":"DNA methylation analysis of the SHOX2 and RASSF1A panel in bronchoalveolar lavage fluid for lung cancer diagnosis","volume":"8","author":"Zhang","year":"2017","journal-title":"J Cancer"},{"key":"10.3233\/CBM-190258_ref14","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.lungcan.2006.11.016","article-title":"Prognostic significance of RASSF1A promoter methylation on survival of non-small cell lung cancer patients treated with gemcitabine","volume":"56","author":"Fischer","year":"2007","journal-title":"Lung Cancer"},{"key":"10.3233\/CBM-190258_ref15","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/PDM.0b013e318240503b","article-title":"DNA methylation of the homeobox genes PITX2 and SHOX2 predicts outcome in non-small-cell lung cancer patients","volume":"21","author":"Dietrich","year":"2012","journal-title":"Diagn Mol Pathol"},{"key":"10.3233\/CBM-190258_ref16","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1158\/1078-0432.CCR-11-2797","article-title":"An apoptosis methylation prognostic signature for early lung cancer in the IFCT-0002 trial","volume":"18","author":"de Fraipont","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.3233\/CBM-190258_ref17","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0002-9440(10)64218-6","article-title":"Establishment and validation of real-time polymerase chain reaction method for CDH1 promoter methylation","volume":"161","author":"Toyooka","year":"2002","journal-title":"Am J Pathol"},{"key":"10.3233\/CBM-190258_ref18","first-page":"3741","article-title":"Aberrant promoter methylation in Chinese patients with non-small cell lung cancer: patterns in primary tumors and potential diagnostic application in bronchoalevolar lavage","volume":"8","author":"Chan","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.3233\/CBM-190258_ref19","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.18632\/aging.101626","article-title":"Accelerated DNA methylation age and the use of antihypertensive medication among older adults","volume":"10","author":"Gao","year":"2018","journal-title":"Aging (Albany NY)"},{"key":"10.3233\/CBM-190258_ref20","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1056\/NEJMoa1214271","article-title":"ERCC1 isoform expression and DNA repair in non-small-cell lung cancer","volume":"368","author":"Friboulet","year":"2013","journal-title":"N Engl J Med"},{"key":"10.3233\/CBM-190258_ref21","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1200\/JCO.2012.46.9783","article-title":"Randomized international phase III trial of ERCC1 and RRM1 expression-based chemotherapy versus gemcitabine\/carboplatin in advanced non-small-cell lung cancer","volume":"31","author":"Bepler","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.3233\/CBM-190258_ref22","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/JTO.0b013e318287c3c5","article-title":"Histology-related associations of ERCC1, RRM1, and TS biomarkers in patients with non-small-cell lung cancer: implications for therapy","volume":"8","author":"Maus","year":"2013","journal-title":"J Thorac Oncol"},{"key":"10.3233\/CBM-190258_ref23","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1586\/14737159.7.5.519","article-title":"CpG islands: their potential as biomarkers for cancer","volume":"7","author":"Shi","year":"2007","journal-title":"Expert Rev Mol Diagn"},{"key":"10.3233\/CBM-190258_ref24","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/nrc755","article-title":"Emerging molecular markers of cancer","volume":"2","author":"Sidransky","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.3233\/CBM-190258_ref25","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/978-1-62703-535-4_4","article-title":"A new, multiplex, quantitative real-time polymerase chain reaction system for nucleic acid detection and quantification","volume":"1039","author":"Liang","year":"2013","journal-title":"Methods Mol Biol"},{"key":"10.3233\/CBM-190258_ref26","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1093\/jnci\/92.19.1601","article-title":"A model to select chemotherapy regimens for phase III trials for extensive-stage small-cell lung cancer","volume":"92","author":"Chen","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.3233\/CBM-190258_ref27","doi-asserted-by":"crossref","first-page":"6982","DOI":"10.1200\/JCO.2005.06.679","article-title":"Comparison of outcomes of phase II studies and subsequent randomized control studies using identical chemotherapeutic regimens","volume":"23","author":"Zia","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.3233\/CBM-190258_ref28","doi-asserted-by":"crossref","first-page":"5941","DOI":"10.1038\/sj.onc.1207789","article-title":"Inactivation of RASSF1C during in vivo tumor growth identifies it as a tumor suppressor gene","volume":"23","author":"Li","year":"2004","journal-title":"Oncogene"},{"key":"10.3233\/CBM-190258_ref29","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/carcin\/bgq266","article-title":"The prognostic value of RASSF1A promoter hypermethylation in non-small cell lung carcinoma: a systematic review and meta-analysis","volume":"32","author":"Wang","year":"2011","journal-title":"Carcinogenesis"},{"key":"10.3233\/CBM-190258_ref30","doi-asserted-by":"crossref","first-page":"6119","DOI":"10.1158\/1078-0432.CCR-04-0652","article-title":"Value of p16INK4a and RASSF1A promoter hypermethylation in prognosis of patients with resectable non-small cell lung cancer","volume":"10","author":"Wang","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.3233\/CBM-190258_ref31","first-page":"2362","article-title":"Clinicopathological significance of epigenetic inactivation of RASSF1A at 3p21.3 in stage I lung adenocarcinoma","volume":"8","author":"Tomizawa","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.3233\/CBM-190258_ref32","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.lungcan.2006.11.016","article-title":"Prognostic significance of RASSF1A promoter methylation on survival of non-small cell lung cancer patients treated with gemcitabine","volume":"56","author":"Fischer","year":"2007","journal-title":"Lung Cancer"},{"key":"10.3233\/CBM-190258_ref33","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s12272-017-0973-3","article-title":"Epigenetic modifications of gene expression by lifestyle and environment","volume":"40","author":"Abdul","year":"2017","journal-title":"Arch Pharm Res"},{"key":"10.3233\/CBM-190258_ref34","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1093\/hmg\/ddi484","article-title":"Post-weaning diet affects genomic imprinting at the insulin-like growth factor 2 (Igf2) locus","volume":"15","author":"Waterland","year":"2006","journal-title":"Hum Mol Genet"},{"key":"10.3233\/CBM-190258_ref35","doi-asserted-by":"crossref","first-page":"e11002","DOI":"10.1371\/journal.pone.0011002","article-title":"High-definition DNA methylation profiles from breast and ovarian carcinoma cell lines with differing doxorubicin resistance","volume":"5","author":"Boettcher","year":"2010","journal-title":"PLoS One"},{"key":"10.3233\/CBM-190258_ref36","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1158\/0008-5472.CAN-17-1492","article-title":"Genomic and epigenomic signatures in ovarian cancer associated with resensitization to platinum drugs","volume":"78","author":"Fang","year":"2018","journal-title":"Cancer Res"},{"key":"10.3233\/CBM-190258_ref37","first-page":"161","article-title":"Role of DNA methylation in cabazitaxel resistance in prostate cancer","volume":"36","author":"Ramachandran","year":"2016","journal-title":"Anticancer Res"},{"key":"10.3233\/CBM-190258_ref38","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1158\/1078-0432.CCR-16-1754","article-title":"Platinum-based chemotherapy induces methylation changes in blood DNA associated with overall survival in patients with ovarian cancer","volume":"23","author":"Flanagan","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.3233\/CBM-190258_ref39","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1080\/15592294.2015.1048953","article-title":"Analysis of DNA methylation and gene expression in radiation-resistant head and neck tumors","volume":"10","author":"Chen","year":"2015","journal-title":"Epigenetics"},{"key":"10.3233\/CBM-190258_ref40","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.4161\/cc.20120","article-title":"Methylation of death-associated protein kinase is associated with cetuximab and erlotinib resistance","volume":"11","author":"Ogawa","year":"2012","journal-title":"Cell Cycle"},{"key":"10.3233\/CBM-190258_ref41","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13148-019-0641-1","article-title":"Impact of chemotherapy for breast cancer on leukocyte DNA methylation landscape and cognitive function: a prospective study","volume":"11","author":"Yao","year":"2019","journal-title":"Clin Epigenetics"},{"key":"10.3233\/CBM-190258_ref42","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S0955-2863(03)00115-3","article-title":"Folate deficiency, mismatch repair-dependent apoptosis, and human disease","volume":"14","author":"Li","year":"2003","journal-title":"J Nutr Biochem"},{"key":"10.3233\/CBM-190258_ref43","doi-asserted-by":"crossref","first-page":"4276s","DOI":"10.1158\/1078-0432.CCR-040010","article-title":"Pemetrexed (ALIMTA), a novel multitargeted antineoplastic agent","volume":"10","author":"Adjei","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.3233\/CBM-190258_ref44","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.lungcan.2006.11.016","article-title":"Prognostic significance of RASSF1A promoter methylation on survival of non-small cell lung cancer patients treated with gemcitabine","volume":"56","author":"Fischer","year":"2007","journal-title":"Lung Cancer"}],"container-title":["Cancer Biomarkers"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/CBM-190258","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:07:25Z","timestamp":1777385245000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/CBM-190258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,3]]},"references-count":44,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3233\/cbm-190258","relation":{},"ISSN":["1875-8592","1574-0153"],"issn-type":[{"value":"1875-8592","type":"electronic"},{"value":"1574-0153","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3,3]]}}}